Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Feb 22

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Feb 22

DOI: 10.23736/S0026-4806.21.07450-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Neuroendocrine neoplasms: what we have learned and what the future holds in the pharmacological treatment

Giovanni VITALE 1, 2 , Luigi BARREA 3, 4, Antonio AVERSA 5

1 Laboratory of Geriatric and Oncologic Neuroendocrinology Research, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy; 2 Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy; 3 Unit of Endocrinology, Dipartimento di Medicina Clinica e Chirurgia, Federico II University Medical School of Naples, Naples, Italy; 4 Centro Italiano per la cura e il Benessere del paziente con Obesità (C.I.B.O), Naples, Italy; 5 Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy


PDF


top of page